Veradermics holder proposes $23.7M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Veradermics, Inc. (MANE) shareholder SR One Capital Fund II Aggregator, LP reported a proposed sale of 217,162 common shares, with an aggregate market value of $23,659,799.9. The notice lists August 12, 2026 as the approximate sale date and Merrill Lynch as broker. The shares were acquired from Veradermics in a cash private placement on October 10, 2025. Sasha Keough signed the notice.
Key Figures
Key Terms
Private Placement financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.